Arcutis Biotherapeutics Statistics
Total Valuation
ARQT has a market cap or net worth of $1.84 billion. The enterprise value is $1.76 billion.
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ARQT has 119.91 million shares outstanding. The number of shares has increased by 29.09% in one year.
| Current Share Class | 119.91M |
| Shares Outstanding | 119.91M |
| Shares Change (YoY) | +29.09% |
| Shares Change (QoQ) | +0.76% |
| Owned by Insiders (%) | 1.81% |
| Owned by Institutions (%) | 81.67% |
| Float | 85.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.30 |
| Forward PS | 4.69 |
| PB Ratio | 13.21 |
| P/TBV Ratio | 14.93 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.20, with a Debt / Equity ratio of 0.79.
| Current Ratio | 3.20 |
| Quick Ratio | 2.86 |
| Debt / Equity | 0.79 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.71 |
Financial Efficiency
Return on equity (ROE) is -57.33% and return on invested capital (ROIC) is -16.68%.
| Return on Equity (ROE) | -57.33% |
| Return on Assets (ROA) | -13.46% |
| Return on Invested Capital (ROIC) | -16.68% |
| Return on Capital Employed (ROCE) | -34.54% |
| Revenue Per Employee | $770,365 |
| Profits Per Employee | -$272,722 |
| Employee Count | 342 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 1.90 |
Taxes
In the past 12 months, ARQT has paid $944,000 in taxes.
| Income Tax | 944,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +40.81% in the last 52 weeks. The beta is 1.94, so ARQT's price volatility has been higher than the market average.
| Beta (5Y) | 1.94 |
| 52-Week Price Change | +40.81% |
| 50-Day Moving Average | 14.95 |
| 200-Day Moving Average | 13.99 |
| Relative Strength Index (RSI) | 49.35 |
| Average Volume (20 Days) | 1,732,055 |
Short Selling Information
The latest short interest is 18.40 million, so 15.35% of the outstanding shares have been sold short.
| Short Interest | 18.40M |
| Short Previous Month | 16.64M |
| Short % of Shares Out | 15.35% |
| Short % of Float | 21.51% |
| Short Ratio (days to cover) | 10.49 |
Income Statement
In the last 12 months, ARQT had revenue of $263.47 million and -$93.27 million in losses. Loss per share was -$0.74.
| Revenue | 263.47M |
| Gross Profit | 234.74M |
| Operating Income | -85.84M |
| Pretax Income | -214.05M |
| Net Income | -93.27M |
| EBITDA | -80.07M |
| EBIT | -85.84M |
| Loss Per Share | -$0.74 |
Full Income StatementBalance Sheet
The company has $190.82 million in cash and $110.16 million in debt, giving a net cash position of $80.66 million or $0.67 per share.
| Cash & Cash Equivalents | 190.82M |
| Total Debt | 110.16M |
| Net Cash | 80.66M |
| Net Cash Per Share | $0.67 |
| Equity (Book Value) | 138.97M |
| Book Value Per Share | 1.16 |
| Working Capital | 228.84M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$65.49 million and capital expenditures -$829,000, giving a free cash flow of -$66.32 million.
| Operating Cash Flow | -65.49M |
| Capital Expenditures | -829,000 |
| Free Cash Flow | -66.32M |
| FCF Per Share | -$0.55 |
Full Cash Flow StatementMargins
Gross margin is 89.10%, with operating and profit margins of -32.58% and -35.40%.
| Gross Margin | 89.10% |
| Operating Margin | -32.58% |
| Pretax Margin | -35.04% |
| Profit Margin | -35.40% |
| EBITDA Margin | -30.39% |
| EBIT Margin | -32.58% |
| FCF Margin | n/a |
Dividends & Yields
ARQT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -29.09% |
| Shareholder Yield | -29.09% |
| Earnings Yield | -5.08% |
| FCF Yield | -3.61% |
Analyst Forecast
The average price target for ARQT is $19.00, which is 24.02% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.00 |
| Price Target Difference | 24.02% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 35.57% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ARQT has an Altman Z-Score of 0.13 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.13 |
| Piotroski F-Score | 3 |
